#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prophylaxis against transplant rejection Huntington's disease Mucopolysaccharidosis I Ocular myasthenia Hereditary spastic paraplegia Lupus nephritis Thalassaemia alpha Epidermolysis bullosa Amyotrophic lateral sclerosis gene carrier Arterial tortuosity syndrome Red blood cell abnormality Univentricular heart Sjogren's syndrome Paroxysmal nocturnal haemoglobinuria Chronic graft versus host disease More trials…

    Learn about Rare Diseases

    Noonan syndrome – Basic Information Hereditary angioedema – Life with Disease Gaucher’s disease type III – Trials in Disease Indolent systemic mastocytosis Mast cell activation syndrome – Treatment Behcet’s syndrome – Diagnostics Short-bowel syndrome – Basic Information Glomerulonephritis membranoproliferative – Trials in Disease Adrenogenital syndrome – Basic Information Ocular melanoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ILOPROST Thiamine Hydrochloride Atezolizumab Specific Nucleic Acid Sna-Xfsb Tapentadol Hydrochloride Surzebiclimab Ecoo15 Lisinopril Brentuximab Vedotin Mercaptopurine Lacutamab Carbamazepine (Ph. Eur.) Amniotic Membrane, Human Aceclofenac Ocrelizumab Gd2Il18Cart Azd5462 ANX007 Linagliptin Vincristine Sulfate More therapies…

    Learn about Your Condition

    Pneumothorax Small intestine leiomyosarcoma Follicular lymphoma stage III Wolfram syndrome Amyloidosis Dupuytren's contracture Retinitis pigmentosa Endometrial stromal sarcoma Arrhythmia Essential thrombocythaemia Agitation postoperative Endocarditis Hyperparathyroidism secondary Krabbe's disease Foot deformity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effects of TAK-341 for Patients with Multiple System Atrophy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Multiple system atrophy
    Investigated Drugs:
    • Human Igg1 Lambda Monoclonal Antibody Against Alfa-Synuclein
    • Saline
    Austria Denmark France Germany Italy Portugal +1

  • Study on Imlifidase for Treating Acute Inflammation in Patients with Neuromyelitis Optica Spectrum Disorder

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuromyelitis optica spectrum disorder
    Investigated Drugs:
    • Imlifidase
    The Netherlands

  • Study of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)

    Not recruiting

    2 1
    Investigated Diseases:
    • Progressive supranuclear palsy
    Investigated Drugs:
    • (S)-N-(5-(4-(1-(Benzo[D][1,3]Dioxol-5-Yl)Ethyl)Piperazin-1-Yl)-1,3,4-Thiadiazol-2-Yl)Acetamide, Hydrochloride Salt
    France Germany Hungary Italy Poland Portugal +1

  • Study on Amantadine and Transcranial Magnetic Stimulation for Reducing Fatigue in Multiple Sclerosis Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Amantadine Hydrochloride
    Spain

  • Study on the Safety of Censavudine (TPN-101) for Patients with Aicardi-Goutières Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Aicardi-Goutieres syndrome
    Investigated Drugs:
    • Censavudine
    France Italy

  • Study of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bulbospinal muscular atrophy congenital
    • Spinal muscular atrophy
    Investigated Drugs:
    • Clenbuterol Hydrochloride
    Italy
Previous Page
1 … 102 103 104 105 106 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!